Info
- Utilizzare la checkbox di selezione a fianco di ciascun documento per attivare le funzionalità di stampa, invio email, download nei formati disponibili del (i) record.
ABC Transporters - 40 Years on [[electronic resource] /] / edited by Anthony M. George
| ABC Transporters - 40 Years on [[electronic resource] /] / edited by Anthony M. George |
| Edizione | [1st ed. 2016.] |
| Pubbl/distr/stampa | Cham : , : Springer International Publishing : , : Imprint : Springer, , 2016 |
| Descrizione fisica | 1 online resource (384 p.) |
| Disciplina | 570 |
| Soggetto topico |
Cell membranes
Biophysics Biological physics Biochemistry Drug resistance Membrane Biology Biological and Medical Physics, Biophysics Biochemistry, general Drug Resistance |
| ISBN | 3-319-23476-5 |
| Formato | Materiale a stampa  |
| Livello bibliografico | Monografia |
| Lingua di pubblicazione | eng |
| Nota di contenuto | ABC Importers -- Inborn errors and potential correction of the cellular expression and localization of medically important ABC transporters -- Human ABC transporter ABCC11: Molecular mechanistic, pharmacological, and anthropological aspects -- Biology of mitochondrial ABCs and their contribution to pathology -- ABC transporters and multidrug resistance in fungi and yeast -- Structural and mechanistic insights into modulation of P-glycoprotein (ABCB1)function by tyrosine kinase inhibitors -- Techniques for the purification of ABC transporters -- HDAC inhibitors and MDR ABC transporters -- The role of polymorphisms in P-glycoprotein (ABCB1) on function -- Interaction of ABC transporters with drugs -- ABC insights from CFTR. |
| Record Nr. | UNINA-9910253873703321 |
| Cham : , : Springer International Publishing : , : Imprint : Springer, , 2016 | ||
| Materiale a stampa | ||
| Lo trovi qui: Univ. Federico II | ||
| ||
Advances in Pharmaceutical Biotechnology [[electronic resource] ] : Recent Progress and Future Applications / / edited by Jayanta Kumar Patra, Amritesh C. Shukla, Gitishree Das
| Advances in Pharmaceutical Biotechnology [[electronic resource] ] : Recent Progress and Future Applications / / edited by Jayanta Kumar Patra, Amritesh C. Shukla, Gitishree Das |
| Edizione | [1st ed. 2020.] |
| Pubbl/distr/stampa | Singapore : , : Springer Singapore : , : Imprint : Springer, , 2020 |
| Descrizione fisica | 1 online resource (xviii, 478 pages) ; 92 illustrations, 56 illustrations in colour |
| Disciplina | 615.19 |
| Soggetto topico |
Pharmaceutical technology
Biomedical engineering Pharmacotherapy Biotechnology Drug resistance Biochemistry Biotecnologia farmacèutica Quimioteràpia Pharmaceutical Sciences/Technology Biomedical Engineering/Biotechnology Drug Resistance Biochemistry, general |
| Soggetto genere / forma | Llibres electrònics |
| ISBN | 981-15-2195-6 |
| Formato | Materiale a stampa |
| Livello bibliografico | Monografia |
| Lingua di pubblicazione | eng |
| Nota di contenuto | Section 1. Traditional And Ethnomedicine -- 1.Traditional Folk Medicine And Drug Discovery: Prospects And Outcome -- 2.Ethnomedicine For Drug Discovery -- 3.Medicinal And Aromatic Plants: Store House To Herbal Antimicrobials -- 4.Ethnomedicinal Plants Of North-East India As A Potential Target For Drug Discovery Against Type 2 Diabetes Mellitus -- 5.Application Of Phytochemicals In Pharmaceuticals -- 6.The Herbal Drugs -- 7.Role Of Natural Products As Alternative Of Synthetic Steroidal Drugs -- 8.Phytochemicals As Therapeutics In Heavy Metal Toxicity -- 9.Phytotherapies For Thyroidism: An Overview -- 10.Phytochemicals As Antidepressants -- 11.Phytochemistry And Medicinal Vaule Of Putranjiva Roxburghii Wall -- 12.Traditional Herbal Practices Of Eastern Ghats, Odisha, India For Treatment Of Bone Fracture -- 13.Screening Of Certain Medicinal Plants Of Manipur For Its Antifungal Activity Against Candida Species -- 14.Phytochemicals And Pharmaceutical: Overview -- 15.Millettia Pachycarpa Benth, A Herbal Medicinal Plant Of Southeast Asia -- 16.Phytochemicals And Their Role In Pharmaceuticals -- Section 2. Drug Discovery, Pharmaceutical Sciences And Future Medicine -- 17.Plant- Mediated Green Synthesis Of Nanoparticles -- 18.Biomedical Applications Of Green Synthesized Nanoparticles -- 19.Role Of Nanoparticles And Nanomaterials In Drug Delivery: An Overview -- 20.Micelleplexes: A Promising Nanocarriers For The Transport Of Genetic Material And Drugs -- 21.Phytomedicines And Their Prospects In Treatment Of Common Skin Diseases -- 22.Microbes As Natural Products For Drug Discovery -- 23.Natural Products From Actinobacteria For Drug Discovery -- 24.Anti – Leprosy Vaccine (Hansen’s Disease Vaccine) -- 25.Exploitation Of Fibrinolytic Enzymes In Combating Blood Clotting Disorders - Recent Advances And Strategies: A Comprehensive Review -- 26.Recent Development In Chronic Inflammation Research And Mangroves As Potential Source Of Anti-Inflammatory Agents -- Section 3. Clinical Trials And Ipr In Pharmaceuticals -- 27.Tissue Engineering And Regenerative Medicines: An Interdisciplinary Understanding -- 28.Ipr: An Overview -- 29.Intellectual Property Rights And Its Role In Natural Product Research -- 30.Nanotechnology In Preclinical Pharmacokinetics. |
| Record Nr. | UNINA-9910733708703321 |
| Singapore : , : Springer Singapore : , : Imprint : Springer, , 2020 | ||
| Materiale a stampa | ||
| Lo trovi qui: Univ. Federico II | ||
| ||
Antibiotic Resistant Bacteria: A Challenge to Modern Medicine [[electronic resource] /] / by Sadhana Sagar, Shilpa Kaistha, Amar Jyoti Das, Rajesh Kumar
| Antibiotic Resistant Bacteria: A Challenge to Modern Medicine [[electronic resource] /] / by Sadhana Sagar, Shilpa Kaistha, Amar Jyoti Das, Rajesh Kumar |
| Autore | Sagar Sadhana |
| Edizione | [1st ed. 2019.] |
| Pubbl/distr/stampa | Singapore : , : Springer Singapore : , : Imprint : Springer, , 2019 |
| Descrizione fisica | 1 online resource (XVI, 179 p. 57 illus., 45 illus. in color.) |
| Disciplina | 616.9041 |
| Soggetto topico |
Drug resistance
Infectious diseases Bacteriology Pharmaceutical technology Drug Resistance Infectious Diseases Pharmaceutical Sciences/Technology Resistència als medicaments |
| Soggetto genere / forma | Llibres electrònics |
| ISBN | 981-13-9879-8 |
| Formato | Materiale a stampa |
| Livello bibliografico | Monografia |
| Lingua di pubblicazione | eng |
| Nota di contenuto | Module 1_Emergence of antibiotic resistant bacteria -- Module 2_Impact of antibiotic resistant bacteria on different field -- Module 3_Antibiotic resistance: Pattern and Mechanisms -- Module 4_Novel strategies for overcoming of antibiotic resistant mechanisms -- Module 5_Future Prospects. |
| Record Nr. | UNINA-9910373917603321 |
Sagar Sadhana
|
||
| Singapore : , : Springer Singapore : , : Imprint : Springer, , 2019 | ||
| Materiale a stampa | ||
| Lo trovi qui: Univ. Federico II | ||
| ||
Antimicrobial Drug Resistance [[electronic resource] ] : Mechanisms of Drug Resistance, Volume 1 / / edited by Douglas L. Mayers, Jack D. Sobel, Marc Ouellette, Keith S. Kaye, Dror Marchaim
| Antimicrobial Drug Resistance [[electronic resource] ] : Mechanisms of Drug Resistance, Volume 1 / / edited by Douglas L. Mayers, Jack D. Sobel, Marc Ouellette, Keith S. Kaye, Dror Marchaim |
| Edizione | [2nd ed. 2017.] |
| Pubbl/distr/stampa | Cham : , : Springer International Publishing : , : Imprint : Springer, , 2017 |
| Descrizione fisica | 1 online resource (XXI, 773 p. 164 illus., 61 illus. in color.) |
| Disciplina | 616.9041 |
| Soggetto topico |
Drug resistance
Infectious diseases Drug Resistance Infectious Diseases |
| ISBN | 3-319-46718-2 |
| Formato | Materiale a stampa |
| Livello bibliografico | Monografia |
| Lingua di pubblicazione | eng |
| Nota di contenuto | History of Drug-Resistant Microbes -- Evolutionary Biology of Drug Resistance -- Pharmacology of Drug Resistance -- Drug Development for Drug-Resistant Pathogens -- Genetic Mechanisms of Transfer of Drug Resistance -- Mutations as a Basis of Antimicrobial Resistance -- Altered Drug Targets -- Enzymatic Modification of Drugs -- Reduced Drug Penetration -- Active Efflux Mechanism -- Biofilms -- Beta-Lactamases -- Penicillin Binding Proteins -- Aminoglycosides -- Tetracyclines and ChloramphenicolQuinolones -- Plasmid Mediated Quinolone Resistance to Macrolides, Lincosamides, and Streptogramins -- Mechanisms of Resistance in Metronidazole -- Glycopeptide-resistance in eneterococci -- Daptomycin Resistance -- Oxazolidinones -- PolymyxinsSulfonamides and Trimethoprim -- Antimycobacterial Agents -- Amphotericin (Polyenes) -- Azoles -- Flucytosine -- Echinocandins -- Antifungal Targets, Mechanisms of Action, and Resistance in Candida albicans -- Herpes Nucleoside Drugs -- Influenza Drugs -- HIV Nucleoside Drugs -- HIV Non-Nucleoside Drugs -- HIV Protease Inhibitors -- HIV Entry Inhibitors -- HIV Integrase Inhibitors -- Hepatitis B -- Hepatitis C -- Agents for anaerobic protozoa -- Antimalarial Agents -- Agents for Leishmania -- Agents for Trypanosomes -- Agents for Toxoplasma -- Agents for Cryptosporidium -- Agents against Nematodes -- Agents against Trematodes and Cestodes -- Agents against Ectoparasites. . |
| Record Nr. | UNINA-9910253931003321 |
| Cham : , : Springer International Publishing : , : Imprint : Springer, , 2017 | ||
| Materiale a stampa | ||
| Lo trovi qui: Univ. Federico II | ||
| ||
Antimicrobial Drug Resistance [[electronic resource] ] : Clinical and Epidemiological Aspects, Volume 2 / / edited by Douglas L. Mayers, Jack D. Sobel, Marc Ouellette, Keith S. Kaye, Dror Marchaim
| Antimicrobial Drug Resistance [[electronic resource] ] : Clinical and Epidemiological Aspects, Volume 2 / / edited by Douglas L. Mayers, Jack D. Sobel, Marc Ouellette, Keith S. Kaye, Dror Marchaim |
| Edizione | [2nd ed. 2017.] |
| Pubbl/distr/stampa | Cham : , : Springer International Publishing : , : Imprint : Springer, , 2017 |
| Descrizione fisica | 1 online resource (XXI, 855 p. 61 illus., 32 illus. in color.) |
| Disciplina | 616.9041 |
| Soggetto topico |
Drug resistance
Infectious diseases Drug Resistance Infectious Diseases |
| ISBN | 3-319-47266-6 |
| Formato | Materiale a stampa |
| Livello bibliografico | Monografia |
| Lingua di pubblicazione | eng |
| Nota di contenuto | History of Drug-Resistant Microbes -- Evolutionary Biology of Drug Resistance -- Pharmacology of Drug Resistance -- Drug Development for Drug-Resistant Pathogens -- Genetic Mechanisms of Transfer of Drug Resistance -- Mutations as a Basis of Antimicrobial Resistance -- Altered Drug Targets -- Enzymatic Modification of Drugs -- Reduced Drug Penetration -- Active Efflux Mechanism -- Biofilms -- Beta-Lactamases -- Penicillin Binding Proteins -- Aminoglycosides -- Tetracyclines and ChloramphenicolQuinolones -- Plasmid Mediated Quinolone Resistance to Macrolides, Lincosamides, and Streptogramins -- Mechanisms of Resistance in Metronidazole -- Glycopeptide-resistance in eneterococci -- Daptomycin Resistance -- Oxazolidinones -- PolymyxinsSulfonamides and Trimethoprim -- Antimycobacterial Agents -- Amphotericin (Polyenes) -- Azoles -- Flucytosine -- Echinocandins -- Antifungal Targets, Mechanisms of Action, and Resistance in Candida albicans -- Herpes Nucleoside Drugs -- Influenza Drugs -- HIV Nucleoside Drugs -- HIV Non-Nucleoside Drugs -- HIV Protease Inhibitors -- HIV Entry Inhibitors -- HIV Integrase Inhibitors -- Hepatitis B -- Hepatitis C -- Agents for anaerobic protozoa -- Antimalarial Agents -- Agents for Leishmania -- Agents for Trypanosomes -- Agents for Toxoplasma -- Agents for Cryptosporidium -- Agents against Nematodes -- Agents against Trematodes and Cestodes -- Agents against Ectoparasites. |
| Record Nr. | UNINA-9910253931103321 |
| Cham : , : Springer International Publishing : , : Imprint : Springer, , 2017 | ||
| Materiale a stampa | ||
| Lo trovi qui: Univ. Federico II | ||
| ||
Antimicrobial Resistance [[electronic resource] ] : Global Challenges and Future Interventions / / edited by Sabu Thomas
| Antimicrobial Resistance [[electronic resource] ] : Global Challenges and Future Interventions / / edited by Sabu Thomas |
| Edizione | [1st ed. 2020.] |
| Pubbl/distr/stampa | Singapore : , : Springer Singapore : , : Imprint : Springer, , 2020 |
| Descrizione fisica | 1 online resource (XIII, 230 p. 20 illus., 16 illus. in color.) |
| Disciplina | 615 |
| Soggetto topico |
Pharmaceutical technology
Pharmacy management Drug resistance Microbiology Pharmaceutical Sciences/Technology Pharmacoeconomics and Health Outcomes Drug Resistance Applied Microbiology Resistència als medicaments Microbiologia |
| Soggetto genere / forma | Llibres electrònics |
| ISBN | 981-15-3658-9 |
| Formato | Materiale a stampa |
| Livello bibliografico | Monografia |
| Lingua di pubblicazione | eng |
| Nota di contenuto | 1) The Evolution of Microbial Defense Systems against Antimicrobial Agents -- 2) Carbapenem Resistance in Gram-negative bacilli: Mechanisms and Challenges -- 3) Influence of Antimicrobials on the Gut Microbiota -- 4) Influence of Abiotic Factors in the Emergence of Antibiotic Resistance -- 5) Polluted Coastal and Estuarine Environments – A Potential Reservoir for AMR Determinants in Various Pathogenic Bacteria -- 6) AMR in Animal Health: Issues and One Health Solutions for LMICs -- 7) Antifungal Resistance: Current Concepts -- 8) 'Planetary Health’ Perspectives and Alternative Approaches to Tackle the AMR Challenge -- 9) Use of Bacterial Cell Wall Recycle Inhibitors to Combat AMR in Bacteria -- 10) Status quo of Omics Technologies in Analyzing the Genetic Mediators of Antimicrobial Resistance at Sub-MIC Concentrations. |
| Record Nr. | UNINA-9910416106703321 |
| Singapore : , : Springer Singapore : , : Imprint : Springer, , 2020 | ||
| Materiale a stampa | ||
| Lo trovi qui: Univ. Federico II | ||
| ||
Antimicrobial Resistance. Global Report on Surveillance [[electronic resource] ] : Global Report on Surveillance
| Antimicrobial Resistance. Global Report on Surveillance [[electronic resource] ] : Global Report on Surveillance |
| Autore | Organization World Health |
| Pubbl/distr/stampa | Geneva, : World Health Organization, 2014 |
| Descrizione fisica | 1 online resource (254 p.) |
| Disciplina | 616 |
| Soggetto topico |
Drug resistance -- Periodicals
Drug resistance in microorganisms Drug resistance Anti-infective agents - Classification Drug resistance in microorganisms - Effect of drugs on Risk management Risk Risk Management Information Science Drug Resistance Microbiological Phenomena Epidemiologic Measurements Therapeutic Uses Probability Pharmacologic Actions Pharmacological Phenomena Public Health Organization and Administration Statistics as Topic Health Services Administration Environment and Public Health Chemical Actions and Uses Physiological Phenomena Health Care Evaluation Mechanisms Health Care Epidemiologic Methods Drug Therapy Quality of Health Care Investigative Techniques Diagnostic Techniques and Procedures Health Care Quality, Access, and Evaluation Anti-Infective Agents Classification Risk Assessment Drug Resistance, Microbial Biology Health & Biological Sciences Microbiology & Immunology |
| Soggetto genere / forma |
Electronic books.
Publication Formats Technical Report |
| ISBN | 92-4-069266-5 |
| Formato | Materiale a stampa |
| Livello bibliografico | Monografia |
| Lingua di pubblicazione | eng |
| Nota di contenuto |
Cover; Contents; Foreword; Summary; Acknowledgements; Abbreviations; Introduction; SECTION 01 Resistance to antibacterial drugs; 1.1 Background; 1.1.1 Limitations; 1.2 Regional surveillance of antibacterial resistance; 1.2.1 WHO African Region; 1.2.2 WHO Region of the Americas; 1.2.3 WHO Eastern Mediterranean Region; 1.2.4 WHO European Region; 1.2.5 WHO South-East Asia Region; 1.2.6 WHO Western Pacific Region; 1.3 References; SECTION 02 Resistance to antibacterial drugs in selected bacteria of international concern; 2.1 Availability of national resistance data; 2.1.1 Key messages
2.2 Resistance data on specific pathogens2.2.1 Escherichia coli - resistance to third-generation cephalosporins and to fluoroquinolones; 2.2.2 Klebsiella pneumoniae - resistance to third-generation cephalosporins and to carbapenems; 2.2.3 Staphylococcus aureus - resistance to methicillin; 2.2.4 Streptococcus pneumoniae - resistance (non-susceptibility) to penicillin; 2.2.5 Nontyphoidal Salmonella - resistance to fluoroquinolones; 2.2.6 Shigella species - resistance to fluoroquinolones; 2.2.7 Neisseria gonorrhoeae - decreased susceptibility to third-generation cephalosporins; 2.3 References SECTION 03 The health and economic burden due to antibacterial resistance3.1 Methods; 3.2 Findings; 3.2.1 Health burden; 3.2.2 Economic burden; 3.3 Knowledge gaps; 3.4 Key messages; 3.5 References; SECTION 04 Surveillance of antimicrobial drug resistance in disease-specific programmes; 4.1 Tuberculosis; 4.1.1 Evolution of drug resistance in tuberculosis; 4.1.2 Surveillance of drug-resistant tuberculosis; 4.1.3 Global public health response to drug-resistant tuberculosis; 4.1.4 Notification of MDR-TB cases and enrolment on treatment 4.1.5 Public health implications: treatment outcomes for multidrug-resistant and extensively drug-resistant tuberculosis4.1.6 Key messages; 4.2 Malaria; 4.2.1 Evolution of antimalarial drug resistance; 4.2.2 Surveillance of antimalarial therapeutic efficacy and resistance; 4.2.3 Global public health implications of antimalarial drug resistance; 4.2.4 Key messages; 4.3 HIV; 4.3.1 Surveillance of anti-HIV drug resistance; 4.3.2 Global public health implications of anti-HIV drug resistance; 4.3.3 Key messages; 4.4 Influenza; 4.4.1 Evolution of resistance in influenza viruses 4.4.2 Anti-influenza drug resistance4.4.3 Surveillance of anti-influenza drug resistance; 4.4.4 Public health implications of anti-influenza drug resistance; 4.4.5 Key messages; 4.5 References; SECTION 05 Surveillance of antimicrobial resistance in other areas; 5.1 Antibacterial resistance in food-producing animals and the food chain; 5.1.1 Ongoing surveillance of antimicrobial resistance in food-producing animals and food; 5.1.2 Integrated surveillance of antimicrobial resistance in foodborne bacteria; 5.1.3 Antimicrobials of particular importance in human and veterinary medicine 5.1.4 Implications for human health from zoonotic transmission of resistant bacteria and genetic material |
| Record Nr. | UNINA-9910511992203321 |
|
Organization World Health
|
||
| Geneva, : World Health Organization, 2014 | ||
| Materiale a stampa | ||
| Lo trovi qui: Univ. Federico II | ||
| ||
Antimicrobial Resistance. Global Report on Surveillance [[electronic resource] ] : Global Report on Surveillance
| Antimicrobial Resistance. Global Report on Surveillance [[electronic resource] ] : Global Report on Surveillance |
| Autore | Organization World Health |
| Pubbl/distr/stampa | Geneva, : World Health Organization, 2014 |
| Descrizione fisica | 1 online resource (254 p.) |
| Disciplina | 616 |
| Soggetto topico |
Drug resistance -- Periodicals
Drug resistance in microorganisms Drug resistance Anti-infective agents - Classification Drug resistance in microorganisms - Effect of drugs on Risk management Risk Risk Management Information Science Drug Resistance Microbiological Phenomena Epidemiologic Measurements Therapeutic Uses Probability Pharmacologic Actions Pharmacological Phenomena Public Health Organization and Administration Statistics as Topic Health Services Administration Environment and Public Health Chemical Actions and Uses Physiological Phenomena Health Care Evaluation Mechanisms Health Care Epidemiologic Methods Drug Therapy Quality of Health Care Investigative Techniques Diagnostic Techniques and Procedures Health Care Quality, Access, and Evaluation Anti-Infective Agents Classification Risk Assessment Drug Resistance, Microbial Biology Health & Biological Sciences Microbiology & Immunology |
| Soggetto genere / forma |
Publication Formats
Technical Report |
| ISBN | 92-4-069266-5 |
| Formato | Materiale a stampa |
| Livello bibliografico | Monografia |
| Lingua di pubblicazione | eng |
| Nota di contenuto |
Cover; Contents; Foreword; Summary; Acknowledgements; Abbreviations; Introduction; SECTION 01 Resistance to antibacterial drugs; 1.1 Background; 1.1.1 Limitations; 1.2 Regional surveillance of antibacterial resistance; 1.2.1 WHO African Region; 1.2.2 WHO Region of the Americas; 1.2.3 WHO Eastern Mediterranean Region; 1.2.4 WHO European Region; 1.2.5 WHO South-East Asia Region; 1.2.6 WHO Western Pacific Region; 1.3 References; SECTION 02 Resistance to antibacterial drugs in selected bacteria of international concern; 2.1 Availability of national resistance data; 2.1.1 Key messages
2.2 Resistance data on specific pathogens2.2.1 Escherichia coli - resistance to third-generation cephalosporins and to fluoroquinolones; 2.2.2 Klebsiella pneumoniae - resistance to third-generation cephalosporins and to carbapenems; 2.2.3 Staphylococcus aureus - resistance to methicillin; 2.2.4 Streptococcus pneumoniae - resistance (non-susceptibility) to penicillin; 2.2.5 Nontyphoidal Salmonella - resistance to fluoroquinolones; 2.2.6 Shigella species - resistance to fluoroquinolones; 2.2.7 Neisseria gonorrhoeae - decreased susceptibility to third-generation cephalosporins; 2.3 References SECTION 03 The health and economic burden due to antibacterial resistance3.1 Methods; 3.2 Findings; 3.2.1 Health burden; 3.2.2 Economic burden; 3.3 Knowledge gaps; 3.4 Key messages; 3.5 References; SECTION 04 Surveillance of antimicrobial drug resistance in disease-specific programmes; 4.1 Tuberculosis; 4.1.1 Evolution of drug resistance in tuberculosis; 4.1.2 Surveillance of drug-resistant tuberculosis; 4.1.3 Global public health response to drug-resistant tuberculosis; 4.1.4 Notification of MDR-TB cases and enrolment on treatment 4.1.5 Public health implications: treatment outcomes for multidrug-resistant and extensively drug-resistant tuberculosis4.1.6 Key messages; 4.2 Malaria; 4.2.1 Evolution of antimalarial drug resistance; 4.2.2 Surveillance of antimalarial therapeutic efficacy and resistance; 4.2.3 Global public health implications of antimalarial drug resistance; 4.2.4 Key messages; 4.3 HIV; 4.3.1 Surveillance of anti-HIV drug resistance; 4.3.2 Global public health implications of anti-HIV drug resistance; 4.3.3 Key messages; 4.4 Influenza; 4.4.1 Evolution of resistance in influenza viruses 4.4.2 Anti-influenza drug resistance4.4.3 Surveillance of anti-influenza drug resistance; 4.4.4 Public health implications of anti-influenza drug resistance; 4.4.5 Key messages; 4.5 References; SECTION 05 Surveillance of antimicrobial resistance in other areas; 5.1 Antibacterial resistance in food-producing animals and the food chain; 5.1.1 Ongoing surveillance of antimicrobial resistance in food-producing animals and food; 5.1.2 Integrated surveillance of antimicrobial resistance in foodborne bacteria; 5.1.3 Antimicrobials of particular importance in human and veterinary medicine 5.1.4 Implications for human health from zoonotic transmission of resistant bacteria and genetic material |
| Record Nr. | UNINA-9910786624203321 |
|
Organization World Health
|
||
| Geneva, : World Health Organization, 2014 | ||
| Materiale a stampa | ||
| Lo trovi qui: Univ. Federico II | ||
| ||
Antimicrobial Resistance. Global Report on Surveillance [[electronic resource] ] : Global Report on Surveillance
| Antimicrobial Resistance. Global Report on Surveillance [[electronic resource] ] : Global Report on Surveillance |
| Autore | Organization World Health |
| Pubbl/distr/stampa | Geneva, : World Health Organization, 2014 |
| Descrizione fisica | 1 online resource (254 p.) |
| Disciplina | 616 |
| Soggetto topico |
Drug resistance -- Periodicals
Drug resistance in microorganisms Drug resistance Anti-infective agents - Classification Drug resistance in microorganisms - Effect of drugs on Risk management Risk Risk Management Information Science Drug Resistance Microbiological Phenomena Epidemiologic Measurements Therapeutic Uses Probability Pharmacologic Actions Pharmacological Phenomena Public Health Organization and Administration Statistics as Topic Health Services Administration Environment and Public Health Chemical Actions and Uses Physiological Phenomena Health Care Evaluation Mechanisms Health Care Epidemiologic Methods Drug Therapy Quality of Health Care Investigative Techniques Diagnostic Techniques and Procedures Health Care Quality, Access, and Evaluation Anti-Infective Agents Classification Risk Assessment Drug Resistance, Microbial Biology Health & Biological Sciences Microbiology & Immunology |
| Soggetto genere / forma |
Publication Formats
Technical Report |
| ISBN | 92-4-069266-5 |
| Formato | Materiale a stampa |
| Livello bibliografico | Monografia |
| Lingua di pubblicazione | eng |
| Nota di contenuto |
Cover; Contents; Foreword; Summary; Acknowledgements; Abbreviations; Introduction; SECTION 01 Resistance to antibacterial drugs; 1.1 Background; 1.1.1 Limitations; 1.2 Regional surveillance of antibacterial resistance; 1.2.1 WHO African Region; 1.2.2 WHO Region of the Americas; 1.2.3 WHO Eastern Mediterranean Region; 1.2.4 WHO European Region; 1.2.5 WHO South-East Asia Region; 1.2.6 WHO Western Pacific Region; 1.3 References; SECTION 02 Resistance to antibacterial drugs in selected bacteria of international concern; 2.1 Availability of national resistance data; 2.1.1 Key messages
2.2 Resistance data on specific pathogens2.2.1 Escherichia coli - resistance to third-generation cephalosporins and to fluoroquinolones; 2.2.2 Klebsiella pneumoniae - resistance to third-generation cephalosporins and to carbapenems; 2.2.3 Staphylococcus aureus - resistance to methicillin; 2.2.4 Streptococcus pneumoniae - resistance (non-susceptibility) to penicillin; 2.2.5 Nontyphoidal Salmonella - resistance to fluoroquinolones; 2.2.6 Shigella species - resistance to fluoroquinolones; 2.2.7 Neisseria gonorrhoeae - decreased susceptibility to third-generation cephalosporins; 2.3 References SECTION 03 The health and economic burden due to antibacterial resistance3.1 Methods; 3.2 Findings; 3.2.1 Health burden; 3.2.2 Economic burden; 3.3 Knowledge gaps; 3.4 Key messages; 3.5 References; SECTION 04 Surveillance of antimicrobial drug resistance in disease-specific programmes; 4.1 Tuberculosis; 4.1.1 Evolution of drug resistance in tuberculosis; 4.1.2 Surveillance of drug-resistant tuberculosis; 4.1.3 Global public health response to drug-resistant tuberculosis; 4.1.4 Notification of MDR-TB cases and enrolment on treatment 4.1.5 Public health implications: treatment outcomes for multidrug-resistant and extensively drug-resistant tuberculosis4.1.6 Key messages; 4.2 Malaria; 4.2.1 Evolution of antimalarial drug resistance; 4.2.2 Surveillance of antimalarial therapeutic efficacy and resistance; 4.2.3 Global public health implications of antimalarial drug resistance; 4.2.4 Key messages; 4.3 HIV; 4.3.1 Surveillance of anti-HIV drug resistance; 4.3.2 Global public health implications of anti-HIV drug resistance; 4.3.3 Key messages; 4.4 Influenza; 4.4.1 Evolution of resistance in influenza viruses 4.4.2 Anti-influenza drug resistance4.4.3 Surveillance of anti-influenza drug resistance; 4.4.4 Public health implications of anti-influenza drug resistance; 4.4.5 Key messages; 4.5 References; SECTION 05 Surveillance of antimicrobial resistance in other areas; 5.1 Antibacterial resistance in food-producing animals and the food chain; 5.1.1 Ongoing surveillance of antimicrobial resistance in food-producing animals and food; 5.1.2 Integrated surveillance of antimicrobial resistance in foodborne bacteria; 5.1.3 Antimicrobials of particular importance in human and veterinary medicine 5.1.4 Implications for human health from zoonotic transmission of resistant bacteria and genetic material |
| Record Nr. | UNINA-9910825162403321 |
|
Organization World Health
|
||
| Geneva, : World Health Organization, 2014 | ||
| Materiale a stampa | ||
| Lo trovi qui: Univ. Federico II | ||
| ||
Antimicrobials [[electronic resource] ] : New and Old Molecules in the Fight Against Multi-resistant Bacteria / / edited by Flavia Marinelli, Olga Genilloud
| Antimicrobials [[electronic resource] ] : New and Old Molecules in the Fight Against Multi-resistant Bacteria / / edited by Flavia Marinelli, Olga Genilloud |
| Edizione | [1st ed. 2014.] |
| Pubbl/distr/stampa | Berlin, Heidelberg : , : Springer Berlin Heidelberg : , : Imprint : Springer, , 2014 |
| Descrizione fisica | 1 online resource (363 p.) |
| Disciplina |
610
615.7 616.9 616.9041 |
| Soggetto topico |
Medical microbiology
Drug resistance Infectious diseases Microbiology Medical Microbiology Drug Resistance Infectious Diseases Applied Microbiology |
| ISBN | 3-642-39968-1 |
| Formato | Materiale a stampa |
| Livello bibliografico | Monografia |
| Lingua di pubblicazione | eng |
| Nota di contenuto |
""Preface""; ""Contents""; ""Part ICurrent Trends in Antibiotics, Pathogens and Medical Needs""; ""1 The Origin and Evolution of Antibiotics""; ""Abstract""; ""1.1�Introduction""; ""1.2�What�s in a Name?""; ""1.3�Many Sources, Uses, and Functions""; ""1.4�How Old Are ��Antibiotics��?""; ""1.5�Antibiotic Myths""; ""1.6�Mode of Action and Evolution of Targets""; ""1.7�Parallel Chemical and Protein Evolution""; ""1.8�Conclusions""; ""References""
""2 Novel Infectious Diseases and Emerging Gram-Positive Multi-Resistant Pathogens in Hospital and Community Acquired Infections""""Abstract""; ""2.1�Introduction""; ""2.2�Methicillin-Resistant S. aureus as a Cause of HospitalHospital- and Community-Acquired InfectionsCommunity-Acquired Infections""; ""2.3�Infections Caused by Glycopeptide-Resistant EnterococciEnterococci""; ""2.4�Issues with Clostridium difficileClostridium difficile Infections""; ""2.5�Conclusions""; ""3 Gram-Negative Pathogens: Overview of Novel and Emerging Resistant Pathogens and Drugs""; ""Abstract"" ""3.1�Introduction""""3.2�MDR, XDR and PDR Pathogens, and Resistance Mechanisms""; ""3.2.1 Resistance to beta -Lactam Antibiotics""; ""3.2.2 Resistance to Aminoglycosides""; ""3.2.3 Resistance to Tigecycline""; ""3.2.4 Resistance to Fluoroquinolones""; ""3.2.5 Resistance to Colistin""; ""3.2.6 Resistance to Phosphonic Acid Derivatives""; ""3.3�Emerging Gram-Negative Resistant Pathogens""; ""3.3.1 Pseudomonas aeruginosa""; ""3.3.1.1 Antibiotic Resistance Mechanisms""; ""3.3.1.2 Risk Factors for Infections and Resistance Development""; ""3.3.2 Acinetobacter baumannii"" ""3.3.2.1 Antibiotic Resistance Mechanisms""""3.3.2.2 Risk Factors for Infections and Resistance Development""; ""3.3.3 Enterobacteriaceae and Klebsiella pneumoniae""; ""3.3.3.1 Antibiotic Resistance Mechanisms""; ""3.3.3.2 Risk Factors for Infections and Resistance Development""; ""3.3.3.3 Klebsiella pneumoniae""; ""3.4�The Complexity of the Resistance Problem""; ""3.4.1 Novel Antimicrobials""; ""3.4.2 Novel beta -Lactam and beta -Lactamase Inhibitors""; ""3.4.2.1 Novel Cephalosporins""; ""3.4.2.2 Novel Carbapenems""; ""3.4.2.3 Novel Monobactams"" ""3.4.2.4 Novel beta -Lactamase Inhibitors""""3.4.3 Novel Non beta -Lactam Antibiotic Compounds""; ""3.4.3.1 Compounds Belonging to Known Class of Antimicrobial Agents""; ""3.4.3.2 Compounds Which Represent New Classes of Antimicrobials""; ""3.5�Conclusions""; ""References""; ""Part IIFamilies of Novel Candidates and Conventional Antibiotics""; ""4 The beta -Lactam Antibiotics: Their Future in the Face of Resistance""; ""Abstract""; ""4.1�Introduction""; ""4.2�Recent Advances in the Chemistry of the beta -Lactams""; ""4.2.1 New Cephalosporins"" ""4.2.1.1 Latest Generation Cephalosporins"" |
| Record Nr. | UNINA-9910298309303321 |
| Berlin, Heidelberg : , : Springer Berlin Heidelberg : , : Imprint : Springer, , 2014 | ||
| Materiale a stampa | ||
| Lo trovi qui: Univ. Federico II | ||
| ||
Soggetto topico
-
Drug Resistance
(78)
- Drug resistance (70)
- Cancer Research (21)
- Cancer research (21)
- Molecular Medicine (17)